Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,888 | -9,109 | -47,349 | -43,020 | -34,097 |
| Depreciation Amortization | 323 | 138 | 552 | 406 | 264 |
| Income taxes - deferred | N/A | N/A | N/A | -1,228 | N/A |
| Accounts receivable | 70 | 57 | 278 | 420 | 128 |
| Accounts payable and accrued liabilities | -984 | -984 | 819 | 827 | 2,607 |
| Other Working Capital | 642 | 1,537 | 10,640 | 12,920 | 6,224 |
| Other Operating Activity | 8,265 | 2,438 | 12,607 | 19,471 | 16,924 |
| Operating Cash Flow | $-15,571 | $-5,923 | $-22,453 | $-10,204 | $-7,951 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -52,434 | -29,056 | -85,014 | -59,474 | -32,728 |
| Purchase Of Investment | -412 | -413 | 675 | 675 | 675 |
| Other Investing Activity | 0 | 0 | -678 | -678 | -678 |
| Investing Cash Flow | $-52,846 | $-29,468 | $-85,018 | $-59,478 | $-32,732 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,914 | 9,492 | 43,872 | 9,332 | 2,983 |
| Debt Repayment | N/A | N/A | -25,000 | -2,846 | N/A |
| Common Stock Issued | 37,416 | 2,065 | 60,859 | 60,831 | 8,265 |
| Other Financing Activity | -490 | -144 | -1,077 | -492 | -561 |
| Financing Cash Flow | $66,840 | $11,413 | $78,655 | $66,825 | $10,687 |
| Exchange Rate Effect | -801 | -1,039 | -3,870 | -2,241 | 571 |
| Beginning Cash Position | 51,043 | 51,043 | 83,728 | 83,728 | 83,728 |
| End Cash Position | 48,665 | 26,025 | 51,043 | 78,632 | 54,304 |
| Net Cash Flow | $-2,378 | $-25,018 | $-32,686 | $-5,097 | $-29,425 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,571 | -5,923 | -22,453 | -10,204 | -7,951 |
| Capital Expenditure | -52,434 | -29,056 | -85,014 | -59,474 | -32,728 |
| Free Cash Flow | -68,004 | -34,979 | -107,467 | -69,678 | -40,679 |